Evaluation of Lithium as a Glycogen-Synthase-Kinase-3 (GSK-3) Inhibitor in Mild Cognitive Impairment
Clinical trial NCT02601859 · COMPLETED
Trial details
- NCT number
- NCT02601859
- Sponsor
- University of Dundee
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2017-06-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.